This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arevalo, J. C.
Right arrow Articles by Perez, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arevalo, J. C.
Right arrow Articles by Perez, P.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2000, p. 5908-5916, Vol. 20, No. 16
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

TrkA Immunoglobulin-Like Ligand Binding Domains Inhibit Spontaneous Activation of the Receptor

Juan C. Arevalo,1 Blanca Conde,2 Barbara L. Hempstead,3 Moses V. Chao,4 Dionisio Martin-Zanca,1 and Pilar Perez1,*

Instituto de Microbiologia Bioquimica, Departamento de Microbiologia y Genetica, CSIC, Universidad de Salamanca. 37007 Salamanca,1 and Departamento de Ciencias Morfologicas, Universidad de Zaragoza, Zaragoza,2 Spain; Hematology/Oncology Division, Weill Medical College of Cornell University, New York, New York 100213; and Molecular Neurobiology Program, Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, New York 100164

Received 11 February 2000/Returned for modification 21 March 2000/Accepted 2 May 2000

The extracellular region of the nerve growth factor (NGF) receptor, TrkA, contains two immunoglobulin (Ig)-like domains that are required for specific ligand binding. We have investigated the possible role of these two Ig-like domains in receptor dimerization and activation by using different mutants of the TrkA extracellular region. Deletions of each Ig-like domain, of both, and of the entire extracellular region were made. To probe the structural constraints on ligand-independent receptor dimerization, chimeric receptors were generated by swapping the Ig-like domains of the TrkA receptor for the third or fourth Ig-like domain of c-Kit. We also introduced single-amino-acid changes in conserved residues within the Ig-like domains of TrkA. Most of these TrkA variants did not bind NGF, and their expression in PC12nnr5 cells, which lack endogenous TrkA, promoted ligand-independent neurite outgrowth. Some TrkA mutant receptors induced malignant transformation of Rat-1 cells, as assessed by measuring proliferation in the absence of serum, anchorage-independent growth, and tumorigenesis in nude mice. These mutants exhibited constitutive phosphorylation and spontaneous dimerization consistent with their biological activities. Our data suggest that spontaneous dimerization of TrkA occurs when the structure of the Ig-like domains is altered, implying that the intact domains inhibit receptor dimerization in the absence of NGF.

* Corresponding author. Mailing address: Instituto de Microbiologia Bioquimica, Departamento de Microbiologia y Genetica, CSIC, Universidad de Salamanca, 37007 Salamanca, Spain. Phone: 34-923-121644. Fax: 34-923-224876. E-mail: piper{at}gugu.usal.es.

Molecular and Cellular Biology, August 2000, p. 5908-5916, Vol. 20, No. 16
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Jang, S.-W., Okada, M., Sayeed, I., Xiao, G., Stein, D., Jin, P., Ye, K. (2007). Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death. Proc. Natl. Acad. Sci. USA 104: 16329-16334 [Abstract] [Full Text]  
  • Ugolini, G., Marinelli, S., Covaceuszach, S., Cattaneo, A., Pavone, F. (2007). The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc. Natl. Acad. Sci. USA 104: 2985-2990 [Abstract] [Full Text]  
  • Woronowicz, A., Amith, S. R., De Vusser, K., Laroy, W., Contreras, R., Basta, S., Szewczuk, M. R. (2007). Dependence of neurotrophic factor activation of Trk tyrosine kinase receptors on cellular sialidase. Glycobiology 17: 10-24 [Abstract] [Full Text]  
  • Wei, X., Ni, S., Correll, P. H. (2005). Uncoupling Ligand-dependent and -independent Mechanisms for Mitogen-activated Protein Kinase Activation by the Murine Ron Receptor Tyrosine Kinase. J. Biol. Chem. 280: 35098-35107 [Abstract] [Full Text]  
  • Oinuma, I., Katoh, H., Negishi, M. (2004). Molecular Dissection of the Semaphorin 4D Receptor Plexin-B1-Stimulated R-Ras GTPase-Activating Protein Activity and Neurite Remodeling in Hippocampal Neurons. J. Neurosci. 24: 11473-11480 [Abstract] [Full Text]  
  • Murray, S. S., Perez, P., Lee, R., Hempstead, B. L., Chao, M. V. (2004). A Novel p75 Neurotrophin Receptor-Related Protein, NRH2, Regulates Nerve Growth Factor Binding to the TrkA Receptor. J. Neurosci. 24: 2742-2749 [Abstract] [Full Text]  
  • Tao, Q., Backer, M. V., Backer, J. M., Terman, B. I. (2001). Kinase Insert Domain Receptor (KDR) Extracellular Immunoglobulin-like Domains 4-7 Contain Structural Features That Block Receptor Dimerization and Vascular Endothelial Growth Factor-induced Signaling. J. Biol. Chem. 276: 21916-21923 [Abstract] [Full Text]  
  • Zaccaro, M. C., Ivanisevic, L., Perez, P., Meakin, S. O., Saragovi, H. U. (2001). p75 Co-receptors Regulate Ligand-dependent and Ligand-independent Trk Receptor Activation, in Part by Altering Trk Docking Subdomains. J. Biol. Chem. 276: 31023-31029 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»